Ivan Bergstein, Chief Executive Officer at STEMLINE THERAPEUTICS INC (STML), sold 112,297 shares at $11.11 ($1.2M) on 2019-03-11, disclosed to the SEC on 2019-03-15.
Seasonal sale ($1.2M) by Chief Executive Officer — this insider has traded STML in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.11 | 55,073 | $612K | 49.0% |
| 2 | $11.11 | 55,073 | $612K | 49.0% |
| 3 | $11.05 | 2,151 | $24K | 1.9% |
| Total | $11.11 avg | 112,297 | $1.2M | 100% |
| Filing → |
| STML | SELL | 2020-02-28 | $316K | — | Filing → |
| STML | SELL | 2020-01-03 | $987K | — | Filing → |
| STML | SELL | 2019-08-16 | $1.0M | — | Filing → |